Anthem Biosciences Ltd (ANTHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039665,
    "name": "Anthem Bioscienc",
    "stock_name": "Anthem Bioscienc",
    "full_name": "Anthem Biosciences Ltd",
    "name_url": "stocks-analysis/anthem-bioscienc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "853.35",
    "chg": 12.55,
    "chgp": "1.49%",
    "dir": 1,
    "prev_price": "840.80",
    "mcapval": "48,324.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 544449,
    "symbol": "ANTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0CZ201020",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "13.49 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-market-returns-4002245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_technicaldot_4002245.png",
        "date": "2026-05-21 08:04:48",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. Despite a recent day decline of 0.87%, the stock’s technical indicators reveal a complex picture of emerging strength tempered by caution, as investors weigh the implications of mixed signals from key momentum and volume metrics."
      },
      {
        "title": "Golden Cross Forms in Anthem Biosciences Ltd — Mixed Technical Signals Cloud the Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4001423",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_goldencross_4001423.png",
        "date": "2026-05-20 18:00:43",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Anthem Biosciences Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.87% on the day the cross formed, while monthly technical indicators remain inconclusive. This divergence between the moving averages and other signals calls for a nuanced analysis of the cross's reliability."
      },
      {
        "title": "Anthem Biosciences Downgraded to Sell Amid Technical Weakness and Financial Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-downgraded-to-sell-amid-technical-weakness-and-financial-setbacks-3998462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_mojoScore_3998462.png",
        "date": "2026-05-19 09:11:12",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 18 May 2026. This shift reflects a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns, despite some positive long-term fundamentals and institutional interest."
      },
      {
        "title": "When is the next results date for Anthem Biosciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-anthem-biosciences-ltd-3990193",
        "imagepath": "",
        "date": "2026-05-13 23:17:43",
        "description": "The next results date for Anthem Biosciences Ltd is scheduled for 19 May 2026...."
      }
    ],
    "total": 15,
    "sid": "10039665",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/anthem-biosciences-10039665"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "27-Jul-2026",
      "details": "Transcript of Earnings Conference Call held on July 22 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "24-Jul-2026",
      "details": "Anthem Biosciences Limited has submitted the Exchange the voting results and a copy of scrutinizer report of the 20th Annual General Meeting of the Company held on July 22 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "22-Jul-2026",
      "details": "Audio recording of Earnings Call for the quarter ended June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Anthem Biosciences Ltd has declared <strong>100%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Market Returns

2026-05-21 08:04:48

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. Despite a recent day decline of 0.87%, the stock’s technical indicators reveal a complex picture of emerging strength tempered by caution, as investors weigh the implications of mixed signals from key momentum and volume metrics.

Golden Cross Forms in Anthem Biosciences Ltd — Mixed Technical Signals Cloud the Outlook

2026-05-20 18:00:43

The 50-day moving average has crossed above the 200-day moving average for Anthem Biosciences Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.87% on the day the cross formed, while monthly technical indicators remain inconclusive. This divergence between the moving averages and other signals calls for a nuanced analysis of the cross's reliability.

Anthem Biosciences Downgraded to Sell Amid Technical Weakness and Financial Setbacks

2026-05-19 09:11:12

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 18 May 2026. This shift reflects a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns, despite some positive long-term fundamentals and institutional interest.

When is the next results date for Anthem Biosciences Ltd?

2026-05-13 23:17:43

The next results date for Anthem Biosciences Ltd is scheduled for 19 May 2026....

View All News